Table 1.
Demographic and baseline characteristics of the patients in the highly purified human menopausal gonadotropin (hp-hMG) and recombinant follicle-stimulating hormone (rFSH) groups.*
| Characteristic | hp-hMG (n = 30) | rFSH (n = 30) | P value |
|---|---|---|---|
| Age (y) | 34.43 (5.722) | 35.10 (5.604) | 0.65 |
| Duration of infertility (y) | 6.97 (3.783) | 6.17 (3.621) | 0.406 |
| BMI | 22.137 (1.410) | 22.390 (1.683) | 0.53 |
| AFC | 4.53 (1.852) | 3.80 (1.955) | 0.141 |
| Basal FSH (IU/mL) | 7.4853 (2.955) | 7.9670 (2.165) | 0.474 |
| LH (IU/mL) | 8.6623 (2.886) | 8.1247 (2.080) | 0.411 |
| E2 (pg/mL) | 43.5230 (15.970) | 47.8007 (22.495) | 0.399 |
| P (ng/mL) | 0.5127 (0.248) | 0.6890 (0.530) | 0.104 |
| T | 0.3270 (0.303) | 0.2450 (0.151) | 0.190 |
| PRL (ng/mL) | 17.9933 (8.858) | 20.3227 (13.800) | 0.440 |
AFC = antral follicle count; BMI = body mass index; FSH = follicle-stimulating hormone; LH = luteinizing hormone; E2 = estradiol; P = progesterone; T = testosterone; PRL = prolactin.
⁎
Values are expressed as mean (SD).